Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG).

Cardiovasc Diabetol · 2017 · PMC5654048 · PMID 29061170

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

Meta-analyses revealed that rosiglitazone was associated with a significant increase in the risk of myocardial infarction (MI) compared with patients not receiving rosiglitazone, and an increase in the risk of CV death that had borderline significance [ 5 , 6 ].

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.